Concert Pharmaceuticals Inc. (CNCE) Gained 7.07% or 1.02 To Price $15.44 On Monday


Concert Pharmaceuticals Inc. (CNCE) gained 7.07% or 1.02 to $15.44. It is near to 260104 shares traded, which is 218.75% compare to the average total volume 118904. The market cap of CNCE is $361.53 million. The year to date change is -39.97%. The 52 week price range is from $12.33 to $30.71. Price of CNCE have changed -0.14% during last week. It have changed 0.70% over last month, -19.35% over last 3 months, -28.04% over last 6 months and -10.66% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNCE is 15.21. It is -1.49% below current price. The 200-day Moving Averages for CNCE is 19.29. It is 24.94% above current price. The 52-week High is 30.71. It is 98.90% from the current price. The 52-week Low is 12.33. It is -20.14% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CNCE is 7.42 on 2018-09-14. Short % to float is 3.12%. There are some statistics of CNCE. It is has market cap $361.53 million. The share outstanding is 23.42 million. The average volume is 118904. The revenue is 143.84M. The percent of top 15 Institution holding is 70.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNCE is 78.32%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNCE is 62.85%.


Tags:

Share this post